AU4931800A - Expression products of genes involved in diseases related to cholesterol metabolism - Google Patents

Expression products of genes involved in diseases related to cholesterol metabolism

Info

Publication number
AU4931800A
AU4931800A AU49318/00A AU4931800A AU4931800A AU 4931800 A AU4931800 A AU 4931800A AU 49318/00 A AU49318/00 A AU 49318/00A AU 4931800 A AU4931800 A AU 4931800A AU 4931800 A AU4931800 A AU 4931800A
Authority
AU
Australia
Prior art keywords
genes involved
diseases related
expression products
cholesterol metabolism
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49318/00A
Other languages
English (en)
Inventor
Isabelle Arnould-Reguigne
Christian Clepet
Patrice Denefle
Catherine Prades
Marie-Francoise Rosier-Montus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU4931800A publication Critical patent/AU4931800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU49318/00A 1999-05-25 2000-05-25 Expression products of genes involved in diseases related to cholesterol metabolism Abandoned AU4931800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9906587 1999-05-25
FR9906587A FR2794131B1 (fr) 1999-05-25 1999-05-25 Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
US13945099P 1999-06-16 1999-06-16
US60139450 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Publications (1)

Publication Number Publication Date
AU4931800A true AU4931800A (en) 2000-12-12

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49318/00A Abandoned AU4931800A (en) 1999-05-25 2000-05-25 Expression products of genes involved in diseases related to cholesterol metabolism

Country Status (11)

Country Link
EP (1) EP1183350A2 (hu)
JP (1) JP2003518918A (hu)
KR (1) KR20020033627A (hu)
AU (1) AU4931800A (hu)
BR (1) BR0010916A (hu)
CA (1) CA2371500A1 (hu)
HU (1) HUP0203164A2 (hu)
IL (1) IL145835A0 (hu)
MX (1) MXPA01011882A (hu)
NO (1) NO20015729L (hu)
WO (1) WO2000071710A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60035163T2 (de) 1999-03-15 2008-02-21 University Of British Columbia, Vancouver Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
AU2001279024B2 (en) 2000-08-01 2007-05-17 Amgen Inc. C3b/C4b complement receptor-like molecules and uses thereof
AT413701B (de) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und Strukturelle und funktionelle charakterisierung von cdw92
JP5618172B2 (ja) 2007-01-05 2014-11-05 国立大学法人東京大学 抗ｐｒｇ−３抗体を用いる癌の診断および治療
CN104109208A (zh) 2007-11-14 2014-10-22 中外制药株式会社 使用抗gpr49抗体的癌症的诊断和治疗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941366A2 (en) * 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
NO20015729L (no) 2002-01-22
WO2000071710A3 (fr) 2001-05-17
CA2371500A1 (fr) 2000-11-30
IL145835A0 (en) 2002-07-25
NO20015729D0 (no) 2001-11-23
MXPA01011882A (es) 2002-05-06
EP1183350A2 (fr) 2002-03-06
WO2000071710A2 (fr) 2000-11-30
HUP0203164A2 (hu) 2002-12-28
BR0010916A (pt) 2002-02-19
KR20020033627A (ko) 2002-05-07
JP2003518918A (ja) 2003-06-17

Similar Documents

Publication Publication Date Title
AU6069300A (en) Novel human genes and gene expression products
AU4053699A (en) Novel human genes and gene expression products
AU9164298A (en) Use of organic acid esters in food products
AU2095599A (en) Human genes and gene expression products i
AU2001285047A1 (en) Human genes and gene expression products
GB2361568B (en) Improvements in or relating to packaging/display of products
AU4187499A (en) Human genes and gene expression products v
AU1100201A (en) Methods of in vivo gene transfer using a sleeping beauty transposon system
PL316200A1 (en) Co-ordinated expression of genes in vivo
AU2001238511A1 (en) Cosmetics to support skin metabolism
AU5319499A (en) Fatty acids to minimize cancer therapy side effects
AU2002365077A1 (en) Methods and products related to non-viral transfection
AU4931800A (en) Expression products of genes involved in diseases related to cholesterol metabolism
WO2000043929A8 (en) Method and system for buyer-initiated aggregating of buyers to obtain desired products at discounted prices
AU4329300A (en) Human mesenchymal dnas and expression products
AU2001297741A1 (en) Compositions and methods relating to breast specific genes and proteins
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
AU2003252979A1 (en) Improvements in or relating to the heating of products
ZA200109129B (en) Expression products of genes involved in diseases related to cholesterol metabolism.
AU6263999A (en) Human genes and gene expression products
AU2003226582A1 (en) Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
AU7954500A (en) Method of in vitro culture of lymphocytes and gene therapy compositions
AU1520599A (en) Somatic transfer of modified genes to predict drug effects
AU1576501A (en) Methods to enhance and confine gene expression in cancer therapy
AU2352301A (en) Gene expression in corneal diseases